Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting epigenetic regulators in the treatment of T-cell lymphoma.

Expert review of hematology - 1 Feb 2020

Ahmed Nada, Feldman Andrew L

Abstract excerpt

Introduction: T-cell lymphomas represent a broad group of malignant T-cell neoplasms with marked molecular, clinical, and biologic heterogeneity. Survival rates after conventional chemotherapy regimens are poor for most subtypes and new therapies are needed. Rapidly expanding knowledge in the field of epigenomics and the development of an increasing number of epigenetic-modifying agents have created new...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Disease-Free Survival
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Lymphoma, T-Cell

Share to Mutation

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 31903826
DOI: 10.1080/17474086.2020.1711732
PMCID: PMC7110907

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting epigenetic regulators in the treatment of T-cell lymphoma.PMID 31903826Read ↗

Histone Modifications and Their Targeting in Lymphoid MalignanciesSemantic proximity Read ↗

Methylation alterations and advance of treatment in lymphomaSemantic proximity Read ↗

Epigenetic Modifications in Lymphoma and Their Role in the Classification of LymphomasSemantic proximity Read ↗

Epigenetic Alterations That Are the Backbone of Immune Evasion in T-Cell MalignanciesSemantic proximity Read ↗

Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies?Semantic proximity Read ↗

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.Semantic proximity Read ↗

Precision therapy for lymphoma--current state and future directions.Semantic proximity Read ↗

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignanciesSemantic proximity Read ↗

Epigenetic therapy in hematological cancersSemantic proximity Read ↗

Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell LymphomaSemantic proximity Read ↗

An update on genetic aberrations in T-cell neoplasms.Semantic proximity Read ↗

The cancer epigenome: Concepts, challenges, and therapeutic opportunities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.